(1-Methyl-1H-indazol-7-yl)methanamine dihydrochloride

Catalog No. :
ACQIBY029
CAS No. :
2725791-01-3
Molecular Formula :
C9H13Cl2N3
Molecular Weight :
234.13

IUPAC Name:(1-methyl-1H-indazol-7-yl)methanamine dihydrochloride

(1-Methyl-1H-indazol-7-yl)methanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$118.00Login to see priceIn stockInquiry
250mg95%$198.00Login to see priceIn stockInquiry
500mg95%$283.00Login to see priceInquiryInquiry
1g95%$423.00Login to see priceInquiryInquiry
5g95%$1288.00Login to see priceInquiryInquiry
10g95%$2176.00Login to see priceInquiryInquiry
25g95%$4483.00Login to see priceInquiryInquiry
50g95%$7305.00Login to see priceInquiryInquiry
100g95%$11690.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Methyl-1H-indazol-7-yl)methanamine dihydrochloride
IUPAC Name(1-methyl-1H-indazol-7-yl)methanamine dihydrochloride
Molecular FormulaC9H13Cl2N3
Molecular Weight234.13
SMILESNCC1=CC=CC2=C1N(C)N=C2.[H]Cl.[H]Cl
InChI KeyPWPBMGRWNBGDEU-UHFFFAOYSA-N
Synonym1H-Indazole-7-methanamine, 1-methyl-, hydrochloride (1:2);(1-Methylindazol-7-yl)methanamine dihydrochloride;(1-methylindazol-7-yl)methanamine;(1-methyl-1H-indazol-7-yl)methanamine dihydrochloride;(1-Methylindazol-7-yl)methanamine dihydrochloride - [M88484]
CAS No.2725791-01-3
PubChem CID155894861

Synthetic Route by SureRoute

1. ACQIBY029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQIBY029 route product structure diagram
    ACQIBY0292725791-01-3 In Stock
Inquiry

2. ACQIBY029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQIBY029 route product structure diagram
    ACQIBY0292725791-01-3 In Stock
Inquiry

Comments (0)